Mitsubishi Tanabe Pays $1.1B For Israeli Clinical Drug Co.
NeuroDerm Ltd. said Monday that Japan's Mitsubishi Tanabe Pharma Corp. will pay $1.1 billion to acquire the Israeli drug manufacturer in a deal the company believes will help bolster its Parkinson's...To view the full article, register now.
Already a subscriber? Click here to view full article